Kelly Helm

Kelly Helm

Company: NephCure

Job title: Executive Director - Patient Engagement

Seminars:

Validating the Relevance of Proteinuria & eGFR Decline in Diverse CKD Populations to be Optimized as Regulatory Accepted Endpoints 8:00 am

Over the past year alone, tremendous efforts have been made to advance research on proteinuria and GFR slope, pushing the boundaries beyond their current scope and expanding into other populations to draw the link more tightly to long term endpoints. Engage in learning, collaboration, and discussions with nephrologists at the forefront of this research to:…Read more

day: Pre-Conference Workshop Day

Panel Discussion | Translating Learnings from IgA Nephropathy to Strive for Acceptable Surrogate Endpoints in Broader CKD 9:00 am

Debating whether hard outcome studies are needed to demonstrate meaningful changes in renal function Extending the emerging learnings from IgA Nephropathy to other orphan kidney diseases Debating the validity of surrogate endpoints for demonstrating renal functionRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.